NASDAQ:LABT | Income Statement | Lakewood-Amedex Biotherapeutics Inc.

Complete source-backed income-statement history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$503,020.00$3.79M-$3.79M$17,652.00-$3.77M-$2.75-$2.751,419,7671,419,767
2026-03-31$507,292.00$182,147.00$886,750.00-$886,750.00-$36,541.00-$923,291.00-$0.20-$0.206,995,4696,995,469
2025-06-30$146,901.00$637,384.00-$637,384.00-$18,559.00-$655,943.00-$1.66-$1.66694,450694,450
2025-03-31$169,703.00$542,609.00-$542,609.00$2,992.00-$539,617.00-$0.15-$0.156,943,4946,943,494

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares